| Name | Title | Contact Details |
|---|
Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.
Nutri-Mack is a Vineland, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.
Paladin Labs Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Paladin Labs Inc. is based in Montréal, QC. You can find more information on Paladin Labs Inc. at www.paladin-labs.com
Triple Ring Technologies is a Newark, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.